ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Emergency Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,670Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 264

$640K Total Retail Price of All Prescriptions

Rank: 2 out of 264

568 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 568 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

20% of this provider’s 568 patients filled at least one prescription for a schedule three drug, compared to an average of 33%.

Risky Drugs to Seniors

6% of this provider’s 9,304 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 11%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $37 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 3.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LISINOPRIL 500 362 1 2
AMLODIPINE BESYLATE 496 375 2 3
HYDROCODONE-ACETAMINOPHEN 475 265 S3 3 1
FUROSEMIDE 364 306 4 8
OMEPRAZOLE 357 275 5 5
LEVOTHYROXINE SODIUM 338 281 6 7
METFORMIN HCL 264 186 7 6
MELOXICAM 261 209 8 26
HYDROCHLOROTHIAZIDE 256 207 9 15
ZOLPIDEM TARTRATE 242 186 10 19
POTASSIUM CHLORIDE 203 189 11 14
SIMVASTATIN 193 149 12 9
CARVEDILOL 184 130 13 23
DONEPEZIL HCL 171 171 14 30
NEXIUM 164 84 15 13
GABAPENTIN 155 100 16 11
NAMENDA 143 143 17 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 137 99 18 12
AMITRIPTYLINE HCL 136 102 R 19 34
LOVASTATIN 128 120 20 37
TRAZODONE HCL 121 57 21 36
ALLOPURINOL 118 94 22 31
METOPROLOL TARTRATE 117 102 23 16
TRAMADOL HCL 113 92 24 4
METOPROLOL SUCCINATE 111 101 25 22
ENALAPRIL MALEATE 105 80 26 69
PREMARIN 102 76 R 27 96
CLOPIDOGREL 99 82 28 41
CYMBALTA 97 60 29 40
PANTOPRAZOLE SODIUM 94 69 30 33
CLONIDINE HCL 91 72 31 56
CITALOPRAM HBR 90 72 32 28
DIGOXIN 86 73 33 104
DOXEPIN HCL 83 68 34 105
PRAVASTATIN SODIUM 81 63 35 17
AZITHROMYCIN 78 48 36 18
TERAZOSIN HCL 76 58 37 108
DIOVAN 76 57 37 65
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 36 39 52
CHLORDIAZEPOXIDE-AMITRIPTYLINE 69 64 R 40 114
ATORVASTATIN CALCIUM 67 47 41 21
SERTRALINE HCL 67 61 41 25
METOCLOPRAMIDE HCL 67 50 41 119
AMLODIPINE BESYLATE-BENAZEPRIL 66 53 44 38
CIPROFLOXACIN HCL 66 48 44 35
CYCLOBENZAPRINE HCL 66 18 R 44 44
SPIRIVA 65 19 47 55
QUETIAPINE FUMARATE 64 46 48 121
PLAVIX 63 52 49 66
WARFARIN SODIUM 60 53 50 24
ESCITALOPRAM OXALATE 59 51 51 59
CLOTRIMAZOLE-BETAMETHASONE 59 45 51 91
DIOVAN HCT 58 41 53 78
CARISOPRODOL 58 0 R 53 27
CELEBREX 58 50 53 81
LANTUS 58 34 53 52
GEMFIBROZIL 57 56 57 92
DILTIAZEM ER 54 54 58 134
ISOSORBIDE MONONITRATE ER 52 38 59 63
GLYBURIDE 51 48 R 60 90
FAMOTIDINE 51 39 60 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.